Malik, Jahanzeb (2021) A Case of Ticagrelor Resistance. European Journal of Case Reports in Internal Medicine, 8 (7). pp. 1-2. ISSN 2284-2594
|
Text
A Case of Ticagrelor Resistance.pdf Download (174kB) | Preview |
Abstract
Ticagrelor is a directly acting cyclopentyltriazolo-pyrimidine which does not require conversion into an active metabolite. It inhibits the P2Y12 receptors on platelets reversibly. Unlike clopidogrel and prasugrel, resistance to ticagrelor is rarely reported. Various mechanisms have been proposed for this resistance. The case of a 62-year-old man with diabetes who had undergone index percutaneous coronary intervention (PCI) 22 days previously is described. The patient presented to us with stent thrombosis. His primary PCI was successfully carried out with a drug-eluting stent. He showed resistance to ticagrelor on thromboelastography platelet mapping. He responded well to prasugrel (another P2Y12 inhibitor) in combination with aspirin.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | Ticagrelor, coronary artery disease, stent thrombosis, dual anti-platelet therapy |
Subjects: | 600 Tecnologia - Scienze applicate 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
Depositing User: | Marina Spanti |
Date Deposited: | 25 Jan 2022 15:54 |
Last Modified: | 25 Jan 2022 15:54 |
URI: | http://eprints.bice.rm.cnr.it/id/eprint/21434 |
Actions (login required)
View Item |